MedPath

sage of Erythropoietin in neonates with brain injury to promote brain development in low and middle income countries.

Phase 3
Conditions
Health Condition 1: P038- Newborn affected by other specified complications of labor and delivery
Registration Number
CTRI/2023/01/049075
Lead Sponsor
Imperial College London
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All inborn babies born at a gestational age > 36 weeks, with a birth weight >2kg will be screened for eligibility and recruited if they meet the inclusion criteria.

Inclusion criteria (Both A and B required)

A.At least one of the following: need for continued resuscitation at 5 minutes of age; 5-minute Apgar score < 6; metabolic acidosis (pH < 7.0; base deficit > 16 mmol/L) in cord or blood gas within the first hour of birth.

B.Moderate or severe neonatal encephalopathy on modified Sarnat staging performed between 1 to 3 hours after birth.

Exclusion Criteria

(i)Imminent death at the time of recruitment

(ii)Babies born at home or another hospital (Out born babies)

(iii)Major congenital malformations

(iv)Head circumference <30 cm at birth

(v)Polycythaemia with a venous haematocrit >65% at the time of recruitment

(vi)Babies undergoing therapeutic hypothermia

(vii)Migrant family or parents unable/unlikely to come back for follow-up at 18 months

(viii)Sentinel event and encephalopathy occurred only after birth

(ix)Unable to consent in primary language of parent(s)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath